title: Alterations in responses of ventral pallidal neurons to excitatory amino acids after long-term dopamine depletion.
abstract: The present study explored the possibility that excitatory amino acid (EAA) sensitivity within the ventral pallidum (VP) is altered by long-term removal of dopamine (DA). Electrophysiological experiments were conducted in chloral hydrate-anesthetized rats 21 to 28 days after they received unilateral substantia nigra injections of the dopaminergic toxin 6-hydroxydopamine (6-OHDA). VP neurons increased firing at low microiontophoretic ejection currents of the EAA agonists N-methyl-D-aspartate (NMDA) and alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA); however, high currents decreased action potential amplitude and rapidly caused cessation of neuronal firing. These responses likely reflected the induction of depolarization block for they were reversed by coiontophoresis of the hyperpolarizing transmitter gamma-aminobutyric acid (GABA) at ejection current levels that normally suppressed firing. The ability of NMDA and AMPA to induce such inactivation was greater in the VP of 6-OHDA-lesioned hemispheres, but unchanged in reserpinized rats, verifying that the alterations in responding to NMDA were the result of chronic, rather than acute, DA removal. The adaptations do not appear to be the consequence of a diminished GABAergic tone for the ability of bicuculline to increase firing (due to blocking a tonic GABAergic input) was not changed. However, low ejection currents of GABA that were insufficient to alter firing rate greatly attenuated the ability of NMDA to induce an apparent depolarization inactivation when coiontophoresed with NMDA onto VP neurons of the lesioned, but not the unlesioned, hemisphere. These studies show that chronic DA removal altered the EAA-induced amplitude-decreasing (i.e., the apparent depolarization inactivation) effects in VP neurons in the absence of a decrease in GABAergic tone.
authors.affiliation: Department of Pharmacology and Experimental Therapeutics, and the Neuroscience Graduate Program, Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois 60153, USA.
authors.forename: Michael S
authors.initials: MS
authors.lastname: Turner
authors.forename: Laurence
authors.initials: L
authors.lastname: Mignon
authors.forename: T Celeste
authors.initials: TC
authors.lastname: Napier
mesh_terms: D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D002851:Chromatography, High Pressure Liquid; D004298:Dopamine / Q000502:physiology*; D004563:Electrochemistry; D004594:Electrophysiology; D018846:Excitatory Amino Acids / Q000494:pharmacology*; D005917:Globus Pallidus / Q000166:cytology / Q000187:drug effects*; D007478:Iontophoresis; D008297:Male; D009474:Neurons / Q000187:drug effects*; D016627:Oxidopamine / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D018091:Receptors, AMPA / Q000187:drug effects; D016194:Receptors, N-Methyl-D-Aspartate / Q000187:drug effects; D012110:Reserpine / Q000494:pharmacology; D009435:Synaptic Transmission / Q000187:drug effects
chemical_list: D018846:Excitatory Amino Acids; D018091:Receptors, AMPA; D016194:Receptors, N-Methyl-D-Aspartate; D012110:Reserpine; D016627:Oxidopamine; D004298:Dopamine